IHS Chemical Week

Chemical Week Magazine :: Business & Finance :: Europe/Mideast

Bayer confirms outlook, acquires nutrition firm

9:04 AM MST | November 9, 2012 | —Natasha Alperowicz

Bayer reported a 17.8% fall in third-quarter net income, to €528 million ($682.2 million) on sales 11.5% higher, at €9.67 billion. Ebitda before special items improved 2.2%, to €1.85 billion. Net income was down because of special charges, particularly for legal claims and restructuring. The company, meanwhile, confirmed earlier forecasts for the whole of 2012. Dekkers: Quarterly sales good all around. Condon: Safeguarding harvests is a major issue. “The upward trend in our life-science businesses, Bayer HealthCare and Bayer CropScience...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Risk Free Trial

Email Address

First Name

Last Name

Click here to register and get your RISK-FREE access to chemweek.com

Not an IHS Chemical Week
24/7 member yet?

Here's why you should be:

  • Searchable online archive access of the last 2 years of Chemical Week.
  • Print or digital magazine subscription
  • Price and market change alerts
  • Economic data and statistics
  • Buyers' Guides
  • Webcasts | whitepapers




contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2015 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa